Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To compare the effect of vaginal dinoprostone versus vaginal misoprostol administered before the copper intrauterine device(IUD) insertion in reducing IUD insertion pain and the difficulty in inserting the IUD in women delivered only by cesarean section.
Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| dinoprostone | Experimental | 1 vaginal tablet of dinoprostone (3mg) (prostinĀ® E2, Pharmacia & Upjohn, Puurs, Belgium) inserted by the study nurse 3 hours before IUD insertion. |
|
| misoprostol | Active Comparator | 1 vaginal tablet of misoprostol (200 mcg) (MisotacĀ®; Sigma Pharma, SAE, Egypt) inserted by the study nurse 3 hours before IUD insertion. |
|
| placebo | Placebo Comparator | one tablet of placebo inserted by the study nurse 3 hours before IUD insertion. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dinoprostone 3 mg | Drug | 1 vaginal tablet of dinoprostone (3mg) (prostinĀ® E2, Pharmacia & Upjohn, Puurs, Belgium) inserted by the study nurse 3 hours before IUD insertion. |
|
| Measure | Description | Time Frame |
|---|---|---|
| The difference in pain scores during intrauterine device insertion | The difference in pain scores during intrauterine device insertion using visual analog scale from 0 to 10 | 10 minutes |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| AHMED SAMY, MD | Contact | +201100681167 | ahmedsamy8233@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| AHMED SAMY | Cairo University | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D015232 | Dinoprostone |
| D016595 | Misoprostol |
| ID | Term |
|---|---|
| D011458 | Prostaglandins E |
| D011453 | Prostaglandins |
| D015777 | Eicosanoids |
| D005231 | Fatty Acids, Unsaturated |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Misoprostol 200Mcg Tab | Drug | 1 vaginal tablet of misoprostol (200 mcg) (MisotacĀ®; Sigma Pharma, SAE, Egypt) inserted by the study nurse 3 hours before IUD insertion. |
|
| placebo | Drug | one tablet of placebo inserted by the study nurse 3 hours before IUD insertion |
|
| D005227 |
| Fatty Acids |
| D008055 | Lipids |
| D012898 | Autacoids |
| D018836 | Inflammation Mediators |
| D001685 | Biological Factors |
| D011459 | Prostaglandins E, Synthetic |
| D011465 | Prostaglandins, Synthetic |